Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa

American Journal of Pathology

Volumn 159, Issue 1, 2001, Pages 149-163

  Johnson, Kristen ^a   Hashimoto, Sanshiro ^b   Lotz, Martin ^b   Pritzker, Kenneth ^c   Terkeltaub, Robert ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; INTERLEUKIN 1; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; ARTICULAR CARTILAGE; BONE MINERALIZATION; CADAVER; CALCINOSIS; CELL LINE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FETUS; HUMAN; KNEE; KNEE MENISCUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REFERENCE VALUE; TISSUE DISTRIBUTION;

CADAVER; CALCIFICATION, PHYSIOLOGIC; CALCINOSIS; CALCIUM; CARTILAGE, ARTICULAR; CELL LINE, TRANSFORMED; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FETUS; HUMANS; INTERLEUKIN-1; KNEE JOINT; MENISCI, TIBIAL; REFERENCE VALUES; TISSUE DISTRIBUTION; TRANSGLUTAMINASES;

EID: 0035403504     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61682-3     Document Type: Article

References (60)

1. Ryan LM, McCarty DJ: Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. Arthritis and Allied Conditions: A Textbook of Rheumatology, ed 13. Edited by W Koopman. Baltimore, Williams and Wilkins, 1997, pp 2103-2126
2. Halverson PB, McCarty D: Basic calcium phosphate (apatite, octacalcium phosphate, tricalcium phosphate) crystal deposition diseases; calcinosis. Arthritis and Allied Conditions: A Textbook of Rheumatology, ed 13. Edited by W Koopman. Baltimore, Williams and Wilkins, 1997, pp 2127-2146
3. Stevens DA, Williams GR: Hormone regulation of chondrocyte differentiation and endochondral bone formation. Mol Cell Endocrinol 1999, 151:195-204
4. Kirsch T, Swoboda B, Nah H: Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000, 8:294-302
5. Goomer R, Johnson K, Burton D, Amiel D, Maris T, Gujral A, Deftos LJ, Terkeltaub RA: Tetrabasic C-Terminal motif determines intracrine regulatory effects of PTHrP 1-173 on PPi metabolism and collagen synthesis in chondrocytes. Endocrinology 2000, 141:4613-4622
6. Terkeltaub R, Lotz M, Johnson K, Deng D, Hashimoto S, Goldring MB, Burton D, Deftos LJ: Parathyroid hormone-related protein is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate. Arthritis Rheum 1998, 41: 2152-2164
7. Eerola I, Salminen H, Lammi P, Lammi M, von der Mark K, Vuorio E, Saamanen AM: Type X collagen, a natural component of mouse articular cartilage: association with growth, aging, and osteoarthritis. Arthritis Rheum 1998, 41:1287-1295
8. Hashimoto S, Takahashi K, Ochs RL, Coutts RD, Amiel D, Lotz M: Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum 1999, 42:2123-2131
9. Ishikawa K, Masuda I, Ohira T, Yokoyama M: A histological study of calcium pyrophosphate dihydrate crystal-deposition disease. J Bone Joint Surg Am 1989, 71:875-886
10. Nurmiskaya M, Magee C, Nurminsky D, Linsenmayer TF: Plasma transglutaminase in hypertrophic chondrocytes: expression and cell-specific intracellular activation produce cell death and externalization. J Cell Biol 1998, 142:1135-1144
11. Linsenmayer TF, Long F, Nurminskaya M, Chen Q, Schmid TM: Type X collagen and other up-regulated components of the avian hypertrophic cartilage program. Prog Nucleic Acid Res Mol Biol 1998, 60:79-109
12. Aeschlimann D, Thomazy V: Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000, 41:1-27
13. Greenberg CS, Birckbichler PJ, Rice RH: Transglutaminases: multifunctional crosslinking enzymes that stabilize tissues. FASEB J 1991, 5:3071-3078
14. Aeschlimann D, Mosher D, Paulsson M: Tissue transglutaminase and factor XIII in cartilage and bone remodeling. Semin Thromb Hemost 1996, 22:437-443
15. Aeschlimann D, Kaupp O, Paulsson M: Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J Cell Biol 1995, 129:881-892
16. Chen JS, Mehta K: Tissue transglutaminase: an enzyme with a split personality. Int J Biochem Cell Biol 1999, 31:817-836
17. 4 and alpha 4beta 1. J Biol Chem 2000, 275: 23589-23595
18. Akimov SS, Krylov D, Fleischman LF, Belkin AM: Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 2000, 148:825-838
19. Rosenthal AK, Gohr CM, Henry LA, Le M: Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage. Arthritis Rheum 2000, 43:1729-1733
20. Melino G, Piacentini M: "Tissue" transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett 1998, 430:59-63
21. Olivero S, Amendola A, Rodolfo C, Spinedi A, Piacentini M: Inhibition of "tissue" transglutaminase increases cell survival by preventing apoptosis. J Biol Chem 1999, 274:34123-34128
22. Fabbi M, Marimpietri D, Martini S, Brancolini C, Amoresano A, Scaloni A, Bargellesi A, Cosulich E: Tissue transglutaminase is a caspase substrate during apoptosis. Cleavage causes loss of transamidating function and is a biochemical marker of caspase 3 activation. Cell Death Differ 1999, 6:992-1001
23. Thomazy VA, Davies PJ: Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification. Cell Death Differ 1999, 6:146-154
24. Rittmaster RS, Thomas LN, Wright AS, Murray SK, Carlson K. Douglas RC, Yung J, Messieh M, Bell D, Lazier CB: The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer. J Urol 1999, 162:2165-2169
25. Muszbek L, Yee VC, Hevessy Z: Blood coagulation factor XIII: structure and function. Thromb Res 1999, 94:271-305
26. Aeschlimann D, Wetterwald A, Fleisch H, Paulsson M: Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation in chondrocytes. J Cell Biol 1993, 120:1461-1470
27. Rosenthal AK, Derfus BA, Henry LA: Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 1997, 40:966-970
28. Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, Jin-Hua P, Sali A, Goding J, Terkeltaub R: Differential mechanisms of PPi production by plasma cell membrane glycoprotein-1 (PC-1) and B10 in chondrocytes. Arthritis Rheum 1999, 42:1986-1997
29. Vincenz C, Dixit VM: 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem 1996, 271:20029-20034
30. Hashimoto S, Ochs RL, Komiya S, Lotz M: Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum 1998, 41:1632-1638
31. Messner K, Gao J: The menisci of the knee joint. Anatomical and functional characteristics, and a rationale for clinical treatment. J Anat 1998, 193:161-178
32. Yoshioka M, Shimizu C, Harwood FL, Courts RD, Amiel D: The effects of hyaluronan during the development of osteoarthritis. Osteoarthritis Cartilage 1997, 5:251-260
33. Hashimoto S, Takahashi K, Ochs RL, Coutts RD, Amiel D, Lotz M: Nitric oxide production and apoptosis in cells of the meniscus during exper mental osteoarthritis. Arthritis Rheum 1999, 42:2123-2131
34. Hashimoto S, Setareh M, Ochs RL, Lotz M: Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 1997, 40:1749-1755
35. Hettasch JM, Peoples KA, Greenberg CS: Analysis of factor XIII substrate specificity using recombinant human factor XIII and tissue transglutaminase chimeras. J Biol Chem 1997, 272:25149-25156
36. Jaattela M, Mouritzen H, Elling F, Bastholm L: A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 1996, 156:1166-1173
37. Reginato AM, Iozzo RV, Jimenez SA: Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum 1994, 37:1338-1349
38. Johnson K, Hashimoto S, Lotz M, Pritzker K, Coding J, Terkeltaub R: Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member plasma cell membrane glycoprotein-1 (PC-1) is both a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum (in press)
39. Johnson K, Moffa A, Pritzker K, Chen Y, Coding J, Terkeltaub R: Matrix vesicle plasma cell membrane glycoprotein-1 (PC-1) regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 1999, 14:883-892
40. Cheng PT, Pritzker KP: The effect of calcium and magnesium ions on calcium pyrophosphate crystal formation in aqueous solutions. J Rheumatol 1981, 8:772-782
41. Cheng PT, Pritzker KP, Kandel RA, Reid A: Analytical scanning and transmission electron microscopy and x-ray microdiffractometry of calcium pyrophosphate dihydrate crystal deposits in tissues. Scanning Electron Microsc 1983, 1:369-377
42. Goldring MB: The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000, 43:1916-1926
43. Studer R, Jaffurs D, Stefanovic-Racic M, Robbins PD, Evans CH: Nitric oxide in osteoarthritis. Osteoarthritis Cart 1999, 7:377-379
44. Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R: Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000, 43:1560-1570
45. Geng Y, Valbracht J, Lotz M: Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest 1996, 98:2425-2430
46. Westacott CI, Barakat AF, Wood L, Perry MJ, Neison P, Bisbinas I, Armstrong L, Millar AB, Elson CJ: Tumor necrosis factor alpha can contribute to focal loss of cartilage in osteoarthritis. Osteoarthritis Cart 2000, 8:213-221
47. Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W, Haegeman G, Beyaert R: The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivatlon signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol 1999, 145:1471-1482
48. Heyninck K, Beyaert R: The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett 1999, 442:147-150
49. Jobin C, Holt L, Bradham CA, Streetz K, Brenner DA, Sartor RB: TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells. J Immunol 1999, 162: 4447-4454
50. Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 1997, 385:540-544
51. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A: Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deflcient mice. Science 2000, 289:2350-2354
52. Grey ST, Arvelo MB, Hasenkamp W, Bach FH, Ferran C: A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med 1999, 190:1135-1146
53. Gaudry CA, Verderio E, Aeschlimann D, Cox A, Smith C, Griffin M: Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem 1999, 274:30707-30714
54. Moldovan F, Pelletier JP, Mineau F, Dupuis M, Cloutier JM, Martel-Pelletier J: Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor beta: role of furin convertase. Arthritis Rheum 2000, 43:2100-2109
55. Krikos A, Laherty CD, Dixit VM: Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem 1992, 267:17971-17976
56. Piredda L, Farrace MG, Lo Bello M, Malorni W, Melino G, Petruzzelli R, Piacentini M: Identification of "tissue" transglutaminase binding proteins in neural cells committed to apoptosis. FASEB J 1999, 13: 355-364
57. Fesus L: Transglutaminase-catalyzed protein cross-linking in the molecular program of apoptosis and its relationship to neuronal processes. Cell Mol Neurobiol 1998, 18:683-694
58. Hashimoto S, Ochs RL, Rosen F, Quach J, McCabe G, Solan J, Seegmiller JE, Terkeltaub R, Lotz M: Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 1998, 95:3094-3099
59. Gohr CM, Rosenthal AK: S 100 in aging articular chondrocytes. Arthritis Rheum 2000, 43:281A
60. Anwar R, Miloszewski KJ: Factor XIII deficiency. Br J Haematol 1999, 107:468-484